| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC44251-1mg |
|
3413-72-7 |
MTIC - Glpbio |
0 | 需询价 | C5H8N6O | |
| GC44250-10mg |
|
472984-79-5 |
MS351 - Glpbio |
0 | 需询价 | C23H21Cl2N3O&;HCl | |
| GC44250-5mg |
|
472984-79-5 |
MS351 - Glpbio |
0 | 需询价 | C23H21Cl2N3O&;HCl | |
| GC44250-1mg |
|
472984-79-5 |
MS351 - Glpbio |
0 | 需询价 | C23H21Cl2N3O&;HCl | |
| GC44249-10mg |
|
228264-19-5 |
MRS2179 (ammonium salt) - Glpbio |
0 | 需询价 | C11H17N5O9P2&;XNH3 | |
| GC44249-5mg |
|
228264-19-5 |
MRS2179 (ammonium salt) - Glpbio |
0 | 需询价 | C11H17N5O9P2&;XNH3 | |
| GC44249-1mg |
|
228264-19-5 |
MRS2179 (ammonium salt) - Glpbio |
0 | 需询价 | C11H17N5O9P2&;XNH3 | |
| GC44248-50mg |
|
22816-60-0 |
MreB Perturbing Compound A22 - Glpbio |
0 | 需询价 | C8H8Cl2N2S&;HCl | |
| GC44248-25mg |
|
22816-60-0 |
MreB Perturbing Compound A22 - Glpbio |
0 | 需询价 | C8H8Cl2N2S&;HCl | |
| GC44248-10mg |
|
22816-60-0 |
MreB Perturbing Compound A22 - Glpbio |
0 | 需询价 | C8H8Cl2N2S&;HCl | |
| GC44247-100mg |
|
138470-70-9 |
Mozavaptan (hydrochloride) - Glpbio |
0 | 需询价 | C27H29N3O2&;HCl | |
| GC44247-50mg |
|
138470-70-9 |
Mozavaptan (hydrochloride) - Glpbio |
0 | 需询价 | C27H29N3O2&;HCl | |
| GC44247-10mg |
|
138470-70-9 |
Mozavaptan (hydrochloride) - Glpbio |
0 | 需询价 | C27H29N3O2&;HCl | |
| GC44247-5mg |
|
138470-70-9 |
Mozavaptan (hydrochloride) - Glpbio |
0 | 需询价 | C27H29N3O2&;HCl | |
| GC44246-10mg |
|
— |
Moxifloxacin N-Sulfate (sodium salt) - Glpbio |
0 | 需询价 | C21H22FN3O7S&;2Na | |
| GC44246-5mg |
|
— |
Moxifloxacin N-Sulfate (sodium salt) - Glpbio |
0 | 需询价 | C21H22FN3O7S&;2Na | |
| GC44246-1mg |
|
— |
Moxifloxacin N-Sulfate (sodium salt) - Glpbio |
0 | 需询价 | C21H22FN3O7S&;2Na | |
| GC44245-25mg |
|
57055-82-0 |
MoTP - Glpbio |
0 | 需询价 | C14H21NO2S | |
| GC44245-10mg |
|
57055-82-0 |
MoTP - Glpbio |
0 | 需询价 | C14H21NO2S | |
| GC44245-5mg |
|
57055-82-0 |
MoTP - Glpbio |
0 | 需询价 | C14H21NO2S | |
小泰
|
010-60710855
|